ResearcherColumbia UniversityNo recent work listed

Stephanie L. Goff

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3317-9804; OpenAlex author ID A5076219640. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper

Papers 2

Neoadjuvant therapy for non-metastatic pancreatic ductal adenocarcinoma. First author DOI 10.1053/j.seminoncol.2014.12.008 ↗
A neoadjuvant strategy for the management of nonmetastatic pancreatic cancer. Co-author DOI 10.1097/ppo.0b013e318279aade ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

John A. Chabot · 2 shared papers, 2012–2015 · strength 0.15
- Paper Neoadjuvant therapy for non-metastatic pancreatic ductal adenocarcinoma. DOI 10.1053/j.seminoncol.2014.12.008 ↗
- Paper A neoadjuvant strategy for the management of nonmetastatic pancreatic cancer. DOI 10.1097/ppo.0b013e318279aade ↗
Megan D. Winner · 1 shared paper, 2015 · strength 0.08
- Paper Neoadjuvant therapy for non-metastatic pancreatic ductal adenocarcinoma. DOI 10.1053/j.seminoncol.2014.12.008 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.